BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Genetown

  Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare

  Agenus Inc. announced the launch of its Biotech Electronic Security Token (BEST), the first digital-security offering in healthcare.

  February 19, 2019

   · 

  4 min read
• Policy

  Chemistree Granted Conditional Use Permit for Desert Hot Springs Land

  Chemistree Technology Inc. is pleased to report that its wholly-owned subsidiary, CHM Desert, LLC, has been granted a Conditional Use Permit by the City of Desert Hot Springs for its 9.55 acre property in located in the City’s cannabis cultivation-friendly zone.

  February 19, 2019

   · 

  6 min read
• BioMidwest

  AbbVie Announces New Drug Application Accepted for Priority Review by U.S. FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis

  Upadacitinib, an investigational once-daily oral JAK1-selective inhibitor, is being studied for the treatment of adult patients with moderate to severe rheumatoid arthritis

  February 19, 2019

   · 

  7 min read
• Deals

  Kindred Biosciences to Announce Fourth Quarter and Year-End 2018 Financial Results

  Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Wednesday, March 6, 2019

  February 19, 2019

   · 

  2 min read
• Business

  Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors

  Experienced Biotech Executive Brings More Than 30 Years of Pharmaceutical and Biotechnology Experience to Genprex

  February 19, 2019

   · 

  5 min read
• Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indications

  GT Gain Therapeutics SA announces that it has closed a €2.5 Million series A financing with VitaTech S.A., Helsinn Investment Fund S.A., and with existing investor TiVenture S.A..

  February 19, 2019

   · 

  4 min read
• Business

  Laboratoire Synbionyme’s Probiotic Skin-Care Products Aim to Revolutionize Beauty Industry

  Probiotics and Prebiotics are not just for your gut; they are the key to healthy, beautiful skin.

  February 19, 2019

   · 

  2 min read
• Business

  Activz Global LLC, Names Vice Admiral Mathias W. Winter to Advisory Board

  Activz Global, LLC is proud to announce the appointment of Vice Admiral Mathias W. Winter to the company’s Board of Advisers.

  February 19, 2019

   · 

  2 min read
• Business

  LAIX Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, February 27, 2019

  LAIX Inc. announced that it will report its fourth quarter and full year 2018 unaudited financial results on Wednesday, February 27, 2019, before the open of the U.S. markets.

  February 19, 2019

   · 

  2 min read
• Significant RayStation Orders From Five UK Cancer Clinics

  Five cancer centers in the UK have placed new orders on the treatment planning system RayStation from RaySearch. The orders strengthen RaySearch’s position in the UK market further.

  February 19, 2019

   · 

  3 min read